Match tier
Listed
Presence
Current · Arkansas
Last published
2026
Sources
OpenAlex · ORCID
Refreshed
2026-08-15
D
Duah Alkam
Researcher
Also affiliated: University of California, Los Angeles (2022); Southwestern Medical Center (2016); Winthrop Rockefeller Foundation (2022–2026); Southwestern Medical Center (2016); The University of Texas Southwestern Medical Center (2016)
Faculty Researcher
11 h-index
31 pubs
508 cited
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Duah Alkam's research focuses on understanding disease mechanisms and developing therapeutic strategies, with recent work investigating novel approaches to cancer immunotherapy and pathogenesis. Publications include the repurposing of the MMR vaccine for cancer immunotherapy and the enhancement of immune response in hepatocellular carcinoma using an oncolytic virus and immune checkpoint blockade. Alkam has also explored insights into SARS-CoV-2 pathogenesis and antiviral drug efficacy using a human precision-cut lung slice platform. Other research areas include multi-omics data integration for understanding triple-negative breast cancer and the epigenetic regulation of integrin β-7 in multiple myeloma. Alkam's work also extends to bacterial virulence factor accumulation in *Staphylococcus aureus* mutants. With an h-index of 11 and 31 publications, Alkam has collaborated extensively with researchers at the University of Arkansas for Medical Sciences, including Charity L. Washam, Stephanie D. Byrum, Allen Gies, and Michael S. Robeson.
Metrics
- h-index: 11
- Publications: 31
- Citations: 508
Selected Publications
-
Class A scavenger receptors promote tumor progression and induce a unique macrophage phenotype in a mouse model of spontaneous breast cancer (2026)
-
Rare SNP in the <i>HELB</i> gene interferes with RPA interaction and cellular function of HELB (2025)
-
IP-to-MS: An Unbiased Workflow for Antigen Profiling (2025)
-
An <i>ex vivo</i> human precision-cut lung slice platform provides insight into SARS-CoV-2 pathogenesis and antiviral drug efficacy (2024)
-
One-pot method for preparing DNA, RNA, and protein for multiomics analysis (2024)
-
An <i>ex vivo</i> human precision-cut lung slice platform provides insight into SARS-CoV-2 pathogenesis and antiviral drug efficacy (2023)
-
Proteogenomics Analysis to Identify Acquired Resistance-Specific Alterations in Melanoma PDXs on MAPKi Therapy (2023)
-
Expression of integrin β-7 is epigenetically enhanced in multiple myeloma subgroups with high-risk cytogenetics (2023)
-
Repurposing live attenuated trivalent MMR vaccine as cost-effective cancer immunotherapy (2022)
-
Proteogenomics Reference Database Protocol v1 (2022)
-
Proteogenomics Reference Database Protocol v1 (2022)
-
Proteogenomics analysis to identify acquired resistance-specific alterations in melanoma PDXs on MAPKi therapy (2022)
-
Is amplification bias consequential in transposon sequencing (TnSeq) assays? A case study with a Staphylococcus aureus TnSeq library subjected to PCR-based and amplification-free enrichment methods (2021)
-
Multi-omics data integration reveals correlated regulatory features of triple negative breast cancer (2021)
-
The Increased Accumulation of Staphylococcus aureus Virulence Factors Is Maximized in a <i>purR</i> Mutant by the Increased Production of SarA and Decreased Production of Extracellular Proteases (2021)
Collaboration Network
Top Collaborators
Stephanie D. Byrum
University of Arkansas for Medical Sciences
12 shared publications
In database
- Multi-omics data integration reveals correlated regulatory features of triple negative breast cancer
- Expression of integrin β-7 is epigenetically enhanced in multiple myeloma subgroups with high-risk cytogenetics
- An <i>ex vivo</i> human precision-cut lung slice platform provides insight into SARS-CoV-2 pathogenesis and antiviral drug efficacy
- One-pot method for preparing DNA, RNA, and protein for multiomics analysis
- Repurposing live attenuated trivalent MMR vaccine as cost-effective cancer immunotherapy
Showing 5 of 12 shared publications
Charity L. Washam
University of Arkansas for Medical Sciences
7 shared publications
In database
- Multi-omics data integration reveals correlated regulatory features of triple negative breast cancer
- One-pot method for preparing DNA, RNA, and protein for multiomics analysis
- Repurposing live attenuated trivalent MMR vaccine as cost-effective cancer immunotherapy
- Proteogenomics analysis to identify acquired resistance-specific alterations in melanoma PDXs on MAPKi therapy
- Proteogenomics Reference Database Protocol v1
Showing 5 of 7 shared publications
Kanishka Manna
University of Arkansas for Medical Sciences
5 shared publications
In database
- Multi-omics data integration reveals correlated regulatory features of triple negative breast cancer
- Proteogenomics analysis to identify acquired resistance-specific alterations in melanoma PDXs on MAPKi therapy
- Proteogenomics Reference Database Protocol v1
- Proteogenomics Reference Database Protocol v1
- Proteogenomics Analysis to Identify Acquired Resistance-Specific Alterations in Melanoma PDXs on MAPKi Therapy
Alan J. Tackett
University of Arkansas for Medical Sciences
5 shared publications
In database
- Expression of integrin β-7 is epigenetically enhanced in multiple myeloma subgroups with high-risk cytogenetics
- Proteogenomics analysis to identify acquired resistance-specific alterations in melanoma PDXs on MAPKi therapy
- Proteogenomics Reference Database Protocol v1
- Proteogenomics Reference Database Protocol v1
- Proteogenomics Analysis to Identify Acquired Resistance-Specific Alterations in Melanoma PDXs on MAPKi Therapy
Prashanthi Dharanipragada
University of California, Los Angeles (US)
4 shared publications
- Proteogenomics analysis to identify acquired resistance-specific alterations in melanoma PDXs on MAPKi therapy
- Proteogenomics Reference Database Protocol v1
- Proteogenomics Reference Database Protocol v1
- Proteogenomics Analysis to Identify Acquired Resistance-Specific Alterations in Melanoma PDXs on MAPKi Therapy
Nathan L. Avaritt
University of Arkansas for Medical Sciences
4 shared publications
In database
- Proteogenomics analysis to identify acquired resistance-specific alterations in melanoma PDXs on MAPKi therapy
- Proteogenomics Reference Database Protocol v1
- Proteogenomics Reference Database Protocol v1
- Proteogenomics Analysis to Identify Acquired Resistance-Specific Alterations in Melanoma PDXs on MAPKi Therapy
Michael S. Robeson
University of Arkansas for Medical Sciences
4 shared publications
In database
- Proteogenomics analysis to identify acquired resistance-specific alterations in melanoma PDXs on MAPKi therapy
- Proteogenomics Reference Database Protocol v1
- Proteogenomics Reference Database Protocol v1
- Proteogenomics Analysis to Identify Acquired Resistance-Specific Alterations in Melanoma PDXs on MAPKi Therapy
Samuel G. Mackintosh
University of Arkansas for Medical Sciences
4 shared publications
In database
- Proteogenomics analysis to identify acquired resistance-specific alterations in melanoma PDXs on MAPKi therapy
- Proteogenomics Reference Database Protocol v1
- Proteogenomics Reference Database Protocol v1
- Proteogenomics Analysis to Identify Acquired Resistance-Specific Alterations in Melanoma PDXs on MAPKi Therapy
Zhentao Yang
University of California, Los Angeles (US)
4 shared publications
- Proteogenomics analysis to identify acquired resistance-specific alterations in melanoma PDXs on MAPKi therapy
- Proteogenomics Reference Database Protocol v1
- Proteogenomics Reference Database Protocol v1
- Proteogenomics Analysis to Identify Acquired Resistance-Specific Alterations in Melanoma PDXs on MAPKi Therapy
Shirley H. Lomeli
University of California, Los Angeles (US)
4 shared publications
- Proteogenomics analysis to identify acquired resistance-specific alterations in melanoma PDXs on MAPKi therapy
- Proteogenomics Reference Database Protocol v1
- Proteogenomics Reference Database Protocol v1
- Proteogenomics Analysis to Identify Acquired Resistance-Specific Alterations in Melanoma PDXs on MAPKi Therapy
Gatien Moriceau
Oldham Council (GB)
4 shared publications
- Proteogenomics analysis to identify acquired resistance-specific alterations in melanoma PDXs on MAPKi therapy
- Proteogenomics Reference Database Protocol v1
- Proteogenomics Reference Database Protocol v1
- Proteogenomics Analysis to Identify Acquired Resistance-Specific Alterations in Melanoma PDXs on MAPKi Therapy
Tung-Chin Chiang
University of Arkansas for Medical Sciences
3 shared publications
In database
- Proteogenomics Reference Database Protocol v1
- Proteogenomics Reference Database Protocol v1
- Proteogenomics Analysis to Identify Acquired Resistance-Specific Alterations in Melanoma PDXs on MAPKi Therapy
Roger S. Lo
University of California, Los Angeles (US)
3 shared publications
- Proteogenomics Reference Database Protocol v1
- Proteogenomics Reference Database Protocol v1
- Proteogenomics Analysis to Identify Acquired Resistance-Specific Alterations in Melanoma PDXs on MAPKi Therapy
Piroon Jenjaroenpun
University of Arkansas for Medical Sciences
2 shared publications
In database
- The Increased Accumulation of Staphylococcus aureus Virulence Factors Is Maximized in a <i>purR</i> Mutant by the Increased Production of SarA and Decreased Production of Extracellular Proteases
- Is amplification bias consequential in transposon sequencing (TnSeq) assays? A case study with a Staphylococcus aureus TnSeq library subjected to PCR-based and amplification-free enrichment methods
Mark S. Smeltzer
University of Arkansas for Medical Sciences
2 shared publications
In database
- The Increased Accumulation of Staphylococcus aureus Virulence Factors Is Maximized in a <i>purR</i> Mutant by the Increased Production of SarA and Decreased Production of Extracellular Proteases
- Is amplification bias consequential in transposon sequencing (TnSeq) assays? A case study with a Staphylococcus aureus TnSeq library subjected to PCR-based and amplification-free enrichment methods
Similar Researchers
Based on overlapping research topics
Claudia J. Beverly
University of Arkansas for Medical Sciences
Disease Mechanisms Research
SARS-CoV-2 and COVID-19 Research
Microbial infections and disease research
Alena V. Savenka
National Center for Toxicological Research
Disease Mechanisms Research
Microbial infections and disease research
Cancer Treatment and Pharmacology
Sydnye Shuttlewoth
University of Arkansas for Medical Sciences
Cancer Immunotherapy and Biomarkers
Disease Mechanisms Research
Molecular Biology Techniques and Applications
J. Y. Suen
University of Arkansas for Medical Sciences
Disease Mechanisms Research
SARS-CoV-2 and COVID-19 Research
Microbial infections and disease research
Rachel S. Palmer
University of Arkansas for Medical Sciences
Disease Mechanisms Research
Microbial infections and disease research
Molecular Biology Techniques and Applications
K K Laffoon
University of Arkansas for Medical Sciences
Disease Mechanisms Research
Microbial infections and disease research
Molecular Biology Techniques and Applications